WinterGreen Research announces that it has a new study on Portable and Transport Ventilator: Market Strategies, Shares, and Forecasts, Worldwide, 2010-2016. Portable ventilators create ways to treat patients with respiratory disease more efficiently. The study has 281 pages and 127 tables and figures.
New portable ventilators have revolutionized the ventilator market, creating units that work across the board in hospital and home situations. This evolution of the portable ventilators means that clinicians have more flexibility of care decisions, moving people home on the same ventilator used in the hospital even without weaning.
Studies have shown that ventilated patients are not a profit center for the hospital, creating incentive for hospitals to move ventilated patients into alternate care delivery settings. As ventilators become smaller, more powerful, and smarter, portable ventilators have become the treatment modality of choice in many cases.
The EnVe™ Ventilator from CareFusion is an example of a comprehensive, full featured pediatric - adult critical care ventilator. The patented ActivCore™ gas delivery system with unprecedented miniaturization allows a single ventilator to deliver true, high-end critical care ventilation - invasive and noninvasively. The modular design of the EnVe system allows detaching the ventilator and moving it with the patient through care areas reducing the need for circuit disconnections and maintaining their level of ventilation. With the EnVe Ventilator, clinicians do not have to compromise patient safety by changing out ventilators for different treatments.
Emerging markets have need for state-of-the-art equipment and value products. A portfolio of value-priced products and services is being adapted to local needs. Healthcare systems work across several modalities. It builds units locally and sells globally.
The aim is to localize care cycles and care settings. Emerging markets are set to become the chronic disease centers of the world. By 2015, China and India will be the largest cardiac markets, and by 2020 three quarters of all cancer deaths will occur in emerging markets.
The fundamental aspect of portable ventilator implementation relates to patient treatment flexibility. The ability to be responsive to changing patient conditions is central to the task of controlling hospital costs. The ability of systems to support flexibility in moving patients to lower cost care delivery sites is anticipated to spur rapid growth of portable and transport ventilators. Portable and transport ventilator markets at $1.2 billion in 2009 are anticipated to reach $2.5 billion by 2016.
SIMILAR MARKET STUDIES
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, and Payer) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Artificial intelligence assists the machines to perform any task without human interventions. It uses different algorithms and software that help the machine to inculcate perception and reasoning for various situations. AI is widely applicable in the healthcare sector for various purposes such as drug discovery and precision medicine. In addition, ...
July 2017 | $5370 | View Details >>
The Global Ursodeoxycholic Acid market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Ursodeoxycholic Acid in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and ...
July 2017 | $4960 | View Details >>
The Ursodeoxycholic Acid market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include ICE Grindeks ...
July 2017 | $3360 | View Details >>
The Global Ursodeoxycholic Acid market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Ursodeoxycholic Acid in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, ...
July 2017 | $4960 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research